Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRFM vs Open Flap Debridement in Periodontal Intraosseous Defects
NCT03616925Phase 3Completed
- Sponsor
- KLE Society's Institute of Dental Sciences
- Start
- Sep 2013
- Primary completion
- Sep 2014
- Modality
- Hydrogel Systems, Recombinant Proteins and Enzymes, Device-based Delivery
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of platelet-rich fibrin matrix in chronic periodontitis (2 arms), sponsored by KLE Society's Institute of Dental Sciences. Primary endpoints: Clinical change in regenerative potential at 6 months, Early Wound Healing Index at 1 week and 1 more. Started Sep 2013; status: completed.
02
Drugs
platelet-rich fibrin matrix
03
Conditions
chronic periodontitis
Beyond the preview
Go deeper on NCT03616925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03616925.